(Q35009768)

5 August 2017

1 reference

title

Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings (English)

1 reference

advanced glycation end-product receptor activity

5 August 2017

main subject

1 reference

Gene Ontology release 2020-05-02

4

Ann Marie Schmidt

1 reference

5 August 2017

David Stern

1

1 reference

5 August 2017

Shi Du Yan

series ordinal

2

1 reference

5 August 2017

Shi Fang Yan

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Advanced Drug Delivery Reviews

5 August 2017

published in

1 reference

5 August 2017

volume

54

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

1615-1625

1 reference

The biology of the receptor for advanced glycation end products and its ligands

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Scavenger receptors in innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

LRP: a multifunctional scavenger and signaling receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Cerebrovascular muscle atrophy is a feature of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

The incidence of cerebral amyloid angiopathy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

The cellular and molecular mechanisms of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Translating cell biology into therapeutic advances in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-beta peptide but not aggregated, cytotoxic amyloid-beta peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3'-kinase to Ras by redox stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900160-6

7 January 2021

10.1016/S0169-409X(02)00160-6

Identifiers

DOI

1 reference

5 August 2017

1 reference